Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Strategies to target long-lived plasma cells for treating hemophilia A inhibitors
Chao Lien Liu
, Meghan J. Lyle
, Simon C. Shin
, Carol H. Miao
School of Medical Laboratory Science and Biotechnology
Ph.D. Program in Medical Biotechnology
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Strategies to target long-lived plasma cells for treating hemophilia A inhibitors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Factor VIII
100%
Plasma Cell
100%
Monospecific Antibody
28%
Mouse
14%
Immune Response
14%
B Cell
14%
Regulatory T Cell
14%
Plasmid
14%
Titer
14%
CD34
14%
Granulocyte Colony-Stimulating Factor
14%
CXCR4
14%
CD20
14%
Chemokine Receptor CXCR4
14%
Chemokine
14%
Plerixafor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Blood Clotting Factor 8
100%
Haemophilia A
100%
Therapeutic Effect
16%
Mouse
16%
Chemokine
16%
Granulocyte Colony Stimulating Factor
16%
Plerixafor
16%
Chemokine Receptor CXCR4
16%
Blood Clotting Factor 8 Inhibitor
16%